Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

9478	Companies
185482	Keywords
117825	Articles
99322	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 03/06/2025 at 07:00, 8 months 30 days ago

Biophytis announces its participation to the BIO-Europe Spring 2025 in Milan
Biophytis announces participation in BIO-Europe Spring 2025 in Milan. Chief Business Officer to attend meetings. Focus on lead drug candidate BIO101 in obesity and sarcopenia

Biophytis Sarcopenia BIO101 Obesity BIO-Europe Spring 2025
BRIEF

published on 02/25/2025 at 07:05, 9 months 8 days ago

Biophytis to Present at 15th International Conference on Frailty and Sarcopenia Research

Biophytis Sarcopenia BIO101 ICFSR 2025 Obesity Research
REGULATED PRESS RELEASE

published on 02/25/2025 at 07:00, 9 months 8 days ago

Biophytis announces its participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR)
Biophytis to participate in ICFSR 15th International Conference on Frailty and Sarcopenia Research, presenting data on BIO101 for obesity-associated sarcopenia. Event in Toulouse, March 12-14

Biophytis Sarcopenia ICFSR BIO101 Obesity
BRIEF

published on 02/11/2025 at 07:05, 9 months 22 days ago

Biophytis Outlines 2025 Strategic Plans

Strategic Partnerships Biophytis Clinical Development Obesity Treatment Sarcopenia
REGULATED PRESS RELEASE

published on 02/11/2025 at 07:00, 9 months 22 days ago

Biophytis unveils its outlook strategies for 2025
Biophytis unveils its strategic outlook for 2025, focusing on clinical development and commercialization plans for BIO101 (20-Hydroxyecdysone) in obesity and sarcopenia, with key partnerships and agreements

Biophytis Clinical Development BIO101 Obesity Strategic Outlook
BRIEF

published on 01/27/2025 at 07:05, 10 months 9 days ago

Biophytis to Participate in BIOMED FORUM Investor Conference

Biophytis Investor Conference Healthcare Sector Paris BIOMED Forum
REGULATED PRESS RELEASE

published on 01/27/2025 at 07:00, 10 months 9 days ago

Biophytis announces its participation to the BIOMED FORUM investor conference
Biophytis announces participation in Biomed Forum investor conference to engage with investors and share updates on developments for age-related diseases

Biophytis Investor Conference Healthcare Sector BIOMED Forum Age-related Diseases
BRIEF

published on 01/21/2025 at 07:05, 10 months 15 days ago

Biophytis and AskHelpU Form Co-Development Partnership in China

Biophytis China ALS Co-development AskHelpU
REGULATED PRESS RELEASE

published on 01/21/2025 at 07:00, 10 months 15 days ago

Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China
Biophy's and AskHelpU sign a co-development agreement for rare neuromuscular diseases in China. The agreement aims to evaluate BIO101's efficacy in ALS, potentially offering a major therapeutic solution for patients

Biophy's ALS AskHelpU Co-development Agreement Neuromuscular Diseases
BRIEF

published on 01/14/2025 at 07:05, 10 months 22 days ago

Biophytis Enters Exclusive Negotiations for BIO101 in China

Biophytis Age-related Diseases BIO101 Pharmaceutical Partnership China Licensing

Accesswire

Published on 12/05/2025 at 15:25, 12 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 37 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 37 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 37 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 13 hours 2 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 15:05, 32 minutes ago

Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 1 hour 15 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 1 hour 20 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 27 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 52 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings

Les Echos

Published on 12/05/2025 at 15:10, 26 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 6 hours 52 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 21 hours 37 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 21 hours 52 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 21 hours 53 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

View all LES ECHOS COMFI WIRE